Feb 25, 2021
When we hear about clinical trials, we might picture doctors and patients partnering to test new therapies. What we might not think about are the teams of other professionals and scholars who make those studies happen and figure out what the results mean.
Dec 7, 2020
EDC Faculty Wendy King publishes work that could help guide clinicians and policymakers in counseling bariatric surgery patients to improve their quality of life for many years to come.
Sep 28, 2020
Glaucoma is the leading cause of irreversible blindness in the world. The condition causes damage to the optic nerve resulting in slow, painless vision loss over many years.
Sep 24, 2020
The National Institutes of Health (NIH) has selected the University of Pittsburgh to lead a trio of Phase 3 clinical trials involving COVID-19 patients. Collectively known as ACTIV-4 Antithrombotics, these trials will explore the use of blood thinners in saving lives and improving care, particularly among adult COVID-19 patients who are at risk of developing life-threatening blood clots.
Sep 24, 2020
The National Eye Institute (NEI) funded the study “Clarifying the Optimal Application of SLT (COAST)” will compare standard SLT to low energy SLT and will also compare retreatment performed as needed when the effect wears off to retreatment annually to maintain eye pressure control without the need for medical therapy.
Feb 3, 2020
Dr. Balasubramani has been to the International society for Influenza and other Respiratory Diseases (ISIRV) for a three-year period.
Aug 1, 2019
Hormone replacement therapy is a common treatment for menopause-related symptoms, and new research from the University of Pittsburgh Graduate School of Public Health reinforces the importance of tailoring hormone therapy to each patient, based on her individual risk factors for cardiovascular disease.
Jul 16, 2019
The clinical trial will assess two treatment strategies for adults with sickle cell disease. In particular, the trial will assess the effectiveness of adding red blood cell exchange transfusion (or erythrocytapheresis) to standard of care medical therapy as compared with the standard of care.